Hepatitis Diagnostic Tests Market Report 2026

Hepatitis Diagnostic Tests Market Overview

• Hepatitis Diagnostic Tests market size has reached to $4.93 billion in 2025 • Expected to grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Increased Blood Transfusions And Donations Fuel Growth In Hepatitis Diagnostic Test Market • Market Trend: Innovative Automated Immunoassays Transform Hepatitis Diagnostic Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hepatitis Diagnostic Tests Market?

Hepatitis diagnostic tests refer to medical examinations and laboratory procedures designed to identify and diagnose hepatitis infections, specifically hepatitis A, B, C, D, and E. These tests aim to detect the presence of hepatitis viruses or specific antibodies in a patient’s blood or other bodily fluids to confirm the infection and determine its type, severity, and progression. The main types of hepatitis diagnostic tests are blood tests, imaging tests, and liver biopsy. Blood tests refer to the examination of blood samples taken from a patient to determine the levels of different blood constituents, such as blood cells, proteins, enzymes, hormones, antibodies, and other chemicals. The various technologies include enzyme-linked immunosorbent assay, rapid diagnostic tests, polymerase chain reaction, isothermal nucleic acid amplification test, and others that are used by various end-users such as hospitals, diagnostic laboratories, and blood banks, and others.

What Is The Hepatitis Diagnostic Tests Market Growth Forecast?

The hepatitis diagnostic tests market size is expected to see strong growth in the next few years. It will grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising investments in advanced molecular testing, expansion of home-based testing solutions, growing focus on early disease detection, increased adoption in low-resource settings. Major trends in the forecast period include increasing adoption of rapid diagnostic tests, rising use of molecular diagnostic technologies, growing integration of automated laboratory systems, expansion of point-of-care testing solutions, enhanced focus on early and accurate diagnosis.

Global Hepatitis Diagnostic Tests Market Segmentation

1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy 2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies 3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users Subsegments: 1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA) 2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) 3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy

What Is The Driver Of The Hepatitis Diagnostic Tests Market?

The rising number of blood transfusions and donations is expected to propel the growth of the hepatitis diagnostic test market going forward. Blood transfusions and blood donation are interconnected processes in which individuals willingly provide their blood, which is collected, tested, and subsequently administered to patients who require additional blood components to treat medical conditions or replace lost blood due to surgeries, accidents, or illnesses. Hepatitis diagnostic tests are used to thoroughly screen blood before donation or transfusion to assure the safety of patients For instance, in August 2023, according to the Royal College of Pathologists, a UK-based organization, blood transfusion is the most frequently performed procedure for hospitalized patients, with nearly 2 million blood components issued and transfused in England annually, costing over £300 ($390.69) million. Therefore, the rising number of blood transfusions and donations drives the hepatitis diagnostic test industry.

Key Players In The Global Hepatitis Diagnostic Tests Market

Major companies operating in the hepatitis diagnostic tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

Global Hepatitis Diagnostic Tests Market Trends and Insights

Major companies operating in the hepatitis diagnostic test market focus on developing innovative automated immunoassays, such as Elecsys HCV Duo, to provide reliable customer service. Elecsys HCV Duo Automated immunoassays are laboratory techniques that use automation systems and specialized instruments to carry out all phases of the immunoassay procedure, such as sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, an India-based biotechnology research company, launched Elecsys HCV Duo. It is India's first commercially available fully automated immunoassay that enables simultaneous and independent assessment of the hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. This also provides single specimen testing and streamlines the diagnostic algorithm, which reduces the number of visits required to take further tests and can lessen the burden of testing on the healthcare system.

What Are Latest Mergers And Acquisitions In The Hepatitis Diagnostic Tests Market?

In October 2024, The Bank of Nova Scotia, a Canada-based company, acquired Bio-Rad Laboratories for an undisclosed amount. With this acquisition, The Bank of Nova Scotia aims to expand its portfolio by incorporating Bio-Rad Laboratorie's expertise in providing products and services for hepatitis diagnostic testing. Bio-Rad Laboratories Inc., is a US-based company that offers diagnostic testing for Hepatitis.

Regional Outlook

North America was the largest region in the hepatitis diagnostic tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hepatitis Diagnostic Tests Market?

The hepatitis diagnostic test market consists of revenues earned by entities by providing diagnostic services such as liver ultrasound, computerized tomography (CT) scans, and antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis diagnostic test market also includes sales of laboratory equipment, reagents, and assay components that are used in providing hepatitis diagnostic test services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hepatitis Diagnostic Tests Market Report 2026?

The hepatitis diagnostic tests market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hepatitis diagnostic tests industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.